Correlation of clinical trachoma and infection in aboriginal communities

PLoS Neglected Tropical Diseases

Volumn 5, Issue 3, 2011, Pages

  Michel, Claude Edouard C ^a   Roper, Katrina G ^b   Divena, Magda A ^a   Lee, Helen H ^a   Taylor, Hugh R ^c,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b The Australian National University   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d The Vision CRC   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; RNA 16S;

ABORIGINE; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; COMMUNITY ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EYE INFLAMMATION; EYE PHOTOGRAPHY; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; PATHOGEN LOAD; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY ANALYSIS; TRACHOMA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DIAGNOSTIC PROCEDURES; EVALUATION; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; OCEANIC ANCESTRY GROUP; SENSITIVITY AND SPECIFICITY; TRACHOMA; YOUNG ADULT;

EID: 79953800333     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000986     Document Type: Article

References (33)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organisation 82: 844-851.
2. Wright HR, Turner A, Taylor HR, (2008) Trachoma. Lancet 371: 1945-1954.
3. Mariotti SP, Pascolini D, Rose-Nussbaumer J, (2009) Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93: 563-568.
4. Solomon AW, Peeling RW, Foster A, Mabey DC, (2004) Diagnosis and assessment of trachoma. Clin Microbiol Rev 17: 982-1011.
5. Taylor HR, (2008) Trachoma: a blinding scourge from the Bronze Age to the twenty-first centory East Melbourne, Viv. Centre for Eye Research Australia, Haddington Press Pty Ltd.
6. Wright HR, Turner A, Taylor HR, (2007) Trachoma and poverty: unnecessary blindness further disadvantages the poorest people in the poorest countries. Clin Exp Optom 90: 422-428.
7. Michel CE, Solomon AW, Magbanua JP, Massae PA, Huang L, et al. (2006) Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet 367: 1585-1590.
8. Solomon AW, Harding-Esch E, Alexander ND, Aguirre A, Holland MJ, et al. (2008) Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N Engl J Med 358: 1870-1871.
9. Miller K, Schmidt G, Melese M, Alemayehu W, Yi E, et al. (2004) How reliable is the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiol 11: 255-262.
10. Solomon AW, Foster A, Mabey DC, (2006) Clinical examination versus Chlamydia trachomatis assays to guide antibiotic use in trachoma control programmes. Lancet Infect Dis 6: 5-6; author reply 7-8.
11. Liu DT, Chan AY, Tai MH, (2006) Clinical examination and laboratory tests for estimation of trachoma prevalence in remote settings. Lancet Infect Dis 6: 7; author reply 7-8.
12. Wright HR, Taylor HR, (2005) Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? Lancet Infect Dis 5: 313-320.
13. Taylor HR, Rapoza PA, West S, Johnson S, Munoz B, et al. (1989) The Epidemiology of Infection in Trachoma. Investigative Ophthalmology & Visual Science 30: 1823-1833.
14. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR, (1987) A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65: 477-483.
15. Roper KG, Taylor HR, (2009) Comparison of clinical and photographic assessment of trachoma. Br J Ophthalmol 93: 811-814.
16. Taylor HR, (1987) Trachoma grading: a new grading scheme. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique pp. 175-181.
17. Roper K, Michel CE, Kelly PM, Taylor HR, (2008) Prevalence of trachoma in Aboriginal communities in the Katherine Region of the Northern Territory in 2007. Med J Aust 189: 409.
18. Lee HH, Dineva MA, inventors. Diagnostics for the Real World, assignee (2002) Improved detection signal and capture In dipstick assays. International patent WO 02/04667.
19. Lee HH, Dineva MA, Fletcher-Brown F, inventors. Cambridge Enterprise, assignee (2008) Nucleic acid amplification and testing. International patent WO 2008090340.
20. Michel CE, Sonnex C, Carne CA, White JA, Magbanua JP, et al. (2007) Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 45: 1395-1402.
21. Wisniewski CA, White JA, Michel CE, Mahilum-Tapay L, Magbanua JP, et al. (2008) Optimal method of collection of first-void urine for diagnosis of Chlamydia trachomatis infection in men. J Clin Microbiol 46: 1466-1469.
22. West SK, Taylor HR, (1990) Reliability of Photographs for Grading Trachoma in Field Studies. British Journal of Ophthalmology 74: 12-13.
23. Bailey IL, Bullimore MA, Raasch TW, Taylor HR, (1991) Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci 32: 422-432.
24. Lee HH, Dineva MA, Chua YL, Ritchie AV, Ushiro-Lumb I, et al. (2010) Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing. J Infect Dis 201 (Suppl 1): S65-72.
25. Wu LT, Curran MD, Ellis J, Parmar S, Ritchie AV, et al. (2010) Nucleic Acid Dipstick Test: Molecular Diagnosis of Pandemic H1N1. J Clin Microbiol.
26. Taylor HR, Johnson SL, Prendergast RA, Schachter J, Dawson CR, et al. (1982) An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci 23: 507-515.
27. Taylor HR, Siler JA, Mkocha HA, Munoz B, West S, (1992) The natural history of endemic trachoma: a longitudinal study. Am J Trop Med Hyg 46: 552-559.
28. Michel CE, (2007) Impact of rapid point-of-care assays for the control of Chlamydia trachomatis infections. Cambridge Open University.
29. Dineva MA, MahiLum-Tapay L, Lee H, (2007) Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings. Analyst 132: 1193-1199.
30. Mabey D, Peeling RW, Ustianowski A, Perkins MD, (2004) Diagnostics for the developing world. Nat Rev Microbiol 2: 231-240.
31. de Barbeyrac B, Goldschmidt P, Malembic S, Raherison S, Clerc M, et al. (2007) Quality assessment of conjunctival specimens for detection of Chlamydia trachomatis by PCR in children with active trachoma. Clin Microbiol Infect 13: 689-694.
32. Schachter J, Hook EW, Martin DH, Willis D, Fine P, et al. (2005) Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol 43: 1372-1373.
33. Chernesky M, Jang D, Luinstra K, Chong S, Smieja M, et al. (2006) High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J Clin Microbiol 44: 400-405.